Respiratory Care Devices Market Analysis

Respiratory care devices benefit patients with chronic and acute respiratory disorders. As we age, the respiratory system goes through major anatomical, psychological, and immunological modifications. Respiratory care devices treat lung ailments such as chronic bronchitis, TB, chronic and acute lung conditions, asthma, and others. As people age, their lungs start to function worse, which leads to changes in the respiratory system's physiology, functionality, and immune system. Asthma and other respiratory conditions are becoming more prevalent, driving market growth. The thoracic spine and chest wall deformities, among other anatomical anomalies, obstruct the function of the respiratory system and lead to breathing issues. The rise in chronic obstructive pulmonary disease has substantially impacted the market for respiratory care devices.

As the world's population ages and environmental variables affect respiratory health, there is more of a demand for respiratory care equipment. The medical supplies and apparatus referred to as respiratory care equipment, assist patients in controlling respiratory conditions or providing breathing support when required. To recognize, treat, and keep track of respiratory problems, these devices are used in various healthcare settings, including clinics, hospitals, and home care settings. Some of the important variables projected to raise the demand for efficient respiratory devices for diagnosing and monitoring respiratory disorders are the rising prevalence of respiratory illnesses, evolving habits, and an increase in pollution levels.

The requirement for respiratory devices is anticipated to expand over the projected period due to rising technological breakthroughs in respiratory equipment, their convenience of use, and the increasing prevalence of different respiratory disorders worldwide. Increasing government and industry spending on R&D initiatives is also anticipated to fuel market expansion for novel respiratory devices throughout the forecast period. Devices that administer therapeutic aerosols, humidify inspired gas, provide more oxygen, and remove airway secretions are all employed in respiratory treatment. Different supplemental oxygen delivery methods have varying degrees of success in increasing the inspired oxygen concentration.

The most recent and serious of these disorders is COVID-19, which has resulted in a surge in demand for personal protective equipment and ventilators, among other things. The market is expected to increase due to factors such as the rising prevalence of respiratory disorders, the growing geriatric population, urbanization and its negative consequences, and changes in the environment and lifestyle. The rising need for point-of-care diagnostic devices in developing countries is expected to open up new prospects for respiratory care device manufacturers. Because of the COVID-19 outbreak, demand for ventilators has increased, leading to government and industry support to accelerate production. As a result of the increased focus on respiratory treatment in the context of an outbreak, the market is likely to develop at a strong rate.

Respiratory Care Devices Market Segment Insights

The respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users.

Respiratory Care Therapeutic Devices Insights

Respiratory Care Monitoring Devices Insights

On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers.

Respiratory Care Diagnostic Devices Insights

Respiratory Care Devices Accessories and Consumables Insights

On the basis of accessories and consumables, the market has been classified as disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables and accessories.

Respiratory Care Devices Application Insights

On the basis of application, the market has been classified as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other diseases.

Respiratory Care Devices End-Users Insights

Respiratory Care Devices Region Insights

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European respiratory care devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The respiratory care devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The respiratory care devices market in the Middle East and Africa has been segmented into the Middle East and Africa.

Respiratory Care Devices Market Regional Market Summary

In the respiratory care devices market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the Centers for Disease Control and Prevention, in 2015, the number of deaths due to chronic lower respiratory diseases (including asthma) in the US were 155,041 and the number of adults diagnosed with chronic bronchitis was 8.9 million.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetic patients, an increasing number of surgeries, and the increasing demand for advanced treatment procedures. According to Eurostat statistics in 2014, there were nearly 382 thousand deaths in the European Union due to respiratory diseases. According to the Global Status Report on Non-Communicable Diseases, 2010 by the World Health Organization (WHO), smoking is predicted to cause about 71% of all lung cancer deaths and 42% of chronic respiratory diseases worldwide.

The Asia-Pacific market is expected to be the fastest growing segment in the near future due to the most dominant causes of respiratory illness and mortality that include tobacco smoking, infections, and air pollution. Factors such as access to optimal treatment facilities, better adoption rate, increase in disposable income, and rising medical tourism help to boost the fastest growing region. The government and NGO's are taking numerous initiatives to spread public awareness and control of the environment regarding the prevention and treatment of respiratory diseases.

The market in the Middle East and Africa is expected to account for the smallest share of the global respiratory care devices market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Industry News Development

Another example is Xplore Health Technologies, which released the Airofit Pro respiratory muscle training (RMT) device in November 2022. This is a result of collaborative work with Airofit from Denmark. It was among the initial smart breathing systems driven by data and retails at $422.74 (Rs34,990). It personalizes the user experience for breathing workouts while increasing the strength, speediness and efficacy of his respiratory muscles.

July 2022: Smile Train launched the Lifebox-Smile Train pulse oximeter together with one of its long-time partners, Lifebox, to scale up access to pulse oximetry for anesthesia and critical care.

July 2022: Omron Healthcare unveiled its new portable oxygen concentrator as part of advances in the oxygen therapy category. It is a medical molecular sieve-based concentrator that provides an uninterrupted stream of high-purity O2.

News:

A technology created by University of Canterbury researchers gives clinicians and patients easier access to respiratory data. A group of PhD students at UC Engineering created software dubbed Breath-to-Breath Observed Biometrics (BOB), which offers real-time breath-to-breath data. It can also evaluate this data and produce a report for doctors to assist in data-driven care. Researchers developed the software after observing how difficult it is for care teams and even patients to access respiratory data. Their creation makes regular condition monitoring and more automated diagnosis possible, which reduces the burden on the entire healthcare system. Physicians can use BOB to modify care if it is no longer the best option.

Key Players

Some of the key players in the global respiratory care devices market are 

• Philips Healthcare (Netherlands


• ResMed, Inc. (US)


• Medtronic plc (Ireland)


• Masimo Corporation (US)


• Fisher & Paykel Healthcare Corporation Limited (New Zealand)


• Becton, Dickinson and Company (US)


• Chart Industries, Inc. (US)


• Drägerwerk AG & Co. KGaA (Germany)


• Hamilton Medical AG (Switzerland)

Respiratory Care Devices Market Segmentation

Respiratory Care Devices Therapeutic Devices Outlook

• Pap devices


• Masks


• Ventilators


• Nebulizers


• Humidifiers


• Oxygen concentrators


• Inhalers


• Reusable resuscitators


• Nitric oxide delivery units


• Oxygen hoods

Respiratory Care Devices Monitoring Devices Outlook

• Pulse oximeters


• Pulse oximeter sensors


• Pulse oximeter equipment


• Capnographs


• Gas analyzers

Respiratory Care Devices Diagnostic Devices Outlook

• Spirometers


• Polysomnography (PSG) Devices


• Peak Flow Meters


• Other Diagnostic Devices

Respiratory Care Devices Accessories and Consumables Outlook

• Disposable masks


• Disposable resuscitators


• Tracheostomy tubes


• Nasal cannulas


• Other consumables and accessories

Respiratory Care Devices Application Outlook

• Chronic obstructive pulmonary disease (COPD)


• Sleep apnea


• Asthma


• Infectious diseases


• Other diseases

Respiratory Care Devices End-Users Outlook

• Hospitals


• Clinics


• Ambulatory care


• Home care 


• Others

Respiratory Care Devices Region Outlook

• North America


• US


• Canada


• South America

• Western Europe


• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe


• Eastern Europe

• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific

• Middle East


• Africa

Recent Development

Intended Audience

• Respiratory care device manufacturers and distributors


• Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)


• Research institutes


• Contract manufacturing organizations (CMOs)


• Government associations


• Market research and consulting firms


• Venture capitalists and investors